The use of estrogen in the treatment of Parkinson's disease

Parkinsonism Relat Disord. 2001 Oct;8(2):133-7. doi: 10.1016/s1353-8020(01)00027-x.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Corpus Striatum / drug effects
  • Dopamine / metabolism
  • Estrogens / therapeutic use*
  • Female
  • Hormone Replacement Therapy
  • Humans
  • Menstrual Cycle
  • Methyltransferases / metabolism
  • Neuroprotective Agents / therapeutic use*
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology
  • Sex Characteristics
  • Substantia Nigra / drug effects

Substances

  • Antiparkinson Agents
  • Estrogens
  • Neuroprotective Agents
  • Methyltransferases
  • caffeate O-methyltransferase
  • Dopamine